Polybrene neutralization as a means of monitoring heparin therapy for extracoporeal cirulation.
暂无分享,去创建一个
E. Foster | R. Berger | C. Valeri | J. I. Spector | L. Talarico | D. Dobnick | J. Umlas
[1] J. Umlas. Fibrinolysis and Disseminated Intravascular Coagulation in Open Heart Surgery , 2003, Transfusion.
[2] A. Silverglade. Biological equivalence of beef lung and hog musosal heparins. , 1975, Current therapeutic research, clinical and experimental.
[3] B. Bull,et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. , 1975, The Journal of thoracic and cardiovascular surgery.
[4] E. Natelson,et al. Rapid determination of fibrinogen by thrombokinetics. , 1974, American journal of clinical pathology.
[5] J. Penner. Experience with a thrombin clotting time assay for measuring heparin activity. , 1974, American journal of clinical pathology.
[6] M. Rotman,et al. Evaluation of the BART test (a modification of the whole-blood activated recalcification time test) as a means of monitoring heparin therapy. , 1974, American journal of clinical pathology.
[7] K. Homewood,et al. Polybrene neutralization as a rapid means of monitoring blood heparin levels. , 1972, American journal of clinical pathology.
[8] Ray Pk,et al. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. , 1971 .
[9] T. Ryan,et al. Reduced Protamine Dosage for Heparin Neutralization in Open‐Heart Operations , 1968, Circulation.
[10] M. Corn,et al. Control of Heparin Therapy With Activated Partial Thromboplastin Times , 1967 .
[11] P. Hattersley. Activated coagulation time of whole blood. , 1966, JAMA.
[12] C. Hougie. The Lee and White test for coagulation time. , 1961, American Journal of Clinical Pathology.
[13] S. Rapaport,et al. CLOTTING FACTOR ASSAYS ON PLASMA FROM PATIENTS RECEIVING INTRAMUSCULAR OF SUBCUTANEOUS HEPARIN , 1957, The American journal of the medical sciences.
[14] P. White,et al. A CLINICAL STUDY OF THE COAGULATION TIME OF BLOOD , 1913 .